Skip to main content
Clinical Trials/NCT05915078
NCT05915078
Recruiting
Not Applicable

Evaluation of Clinical and Health Economic Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry

Smith & Nephew, Inc.6 sites in 1 country200 target enrollmentJune 15, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Otitis Media With Effusion
Sponsor
Smith & Nephew, Inc.
Enrollment
200
Locations
6
Primary Endpoint
Procedure Success
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This prospective, single-arm, multicenter registry is being conducted to collect real world post-market data from patients aged from 6 months to 17 years of age who are undergoing an in-office ear tube placement procedure (tympanostomy) using the Tula® System. The Registry will include up to 20 centers in the US and up to 200 patients for the initial evaluation.

The FDA-approved Tula System includes the Tula Iontophoresis System (IPS) with TYMBION™ otic anesthetic for local anesthesia of the ear drum and the Tula Tube Delivery System (TDS) for ear tube placement. Clinical research established the safety, efficacy and tolerability of this system for in-office procedures in the pediatric population. Patients will be treated and evaluated according to standard medical care. Outcome data is collected up to 6 months following extrusion or removal of their tube(s).

Registry
clinicaltrials.gov
Start Date
June 15, 2023
End Date
June 30, 2027
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients ages 6 months through 17 years of age (inclusive) at time of tympanostomy in-office using the Tula® System
  • Patients who are candidates for in-office tube placement using the Tula System according to the System Instructions For Use

Exclusion Criteria

  • Patients who are wards are not included

Outcomes

Primary Outcomes

Procedure Success

Time Frame: Day of procedure (day 0)

Count (and percentage) of patients with successful placement of Tula Tympanostomy Tubes in all indicated ears in an office procedure

Secondary Outcomes

  • Tolerability (physician reported)(Day of procedure (day 0))
  • Overall parent satisfaction(1 month post-procedure)
  • Tolerability (parent reported) - anesthesia(Day of procedure (day 0))
  • Recovery (physician reported)(Day of procedure (day 0))
  • Recovery (parent reported)(Day of procedure (day 0))
  • Anesthesia effectiveness - patients(Day of procedure (day 0))
  • Parent satisfaction (informed)(1 month post-procedure)
  • Anesthesia effectiveness - ears(Day of procedure (day 0))
  • Tula Tympanostomy Tube retention(1 month post procedure)
  • Tolerability (parent reported) - procedure(Day of procedure (day 0))
  • Parent satisfaction (siblings)(1 month post-procedure)
  • Parent satisfaction (recommendation)(1 month post-procedure)

Study Sites (6)

Loading locations...

Similar Trials